US equities |
SPCX $171.09 ▲+0.00% NVDA $238.90 ▲+0.00% MU $1,063.96 ▲+0.00% SDEV $3.94 ▲+0.00% SNDK $1,704.16 ▲+0.00% SKHY $195.02 ▲+0.00% TSLA $378.73 ▲+0.00% INTC $116.19 ▲+0.00%
FinancialContent

Articles published by X4 Pharmaceuticals

News headline image
X4 Pharmaceuticals to Participate in Guggenheim’s Emerging Outlook: Biotech Summit 2026
From X4 Pharmaceuticals
Via GlobeNewswire
Tickers XFOR
News headline image
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From X4 Pharmaceuticals
Via GlobeNewswire
Tickers XFOR
News headline image
X4 Pharmaceuticals to Participate in Guggenheim’s Second Annual Healthcare Innovation Conference
From X4 Pharmaceuticals
Via GlobeNewswire
Tickers XFOR
News headline image
X4 Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
From X4 Pharmaceuticals
Via GlobeNewswire
Tickers XFOR
News headline image
X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million
From X4 Pharmaceuticals
Via GlobeNewswire
Tickers XFOR
News headline image
X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering
From X4 Pharmaceuticals
Via GlobeNewswire
Tickers XFOR
News headline image
X4 Pharmaceuticals Announces Proposed Underwritten Public Offering
From X4 Pharmaceuticals
Via GlobeNewswire
Tickers XFOR
News headline image
X4 Pharmaceuticals Announces Restructuring of Business Operations Designed to Drive Long-Term Value Creation
From X4 Pharmaceuticals
Via GlobeNewswire
Tickers XFOR